GET THE APP

Inosine 5’-monophosphate dehydrogenase (IMPDH) as an anticancer target: Renewed interest and recent progress
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Inosine 5’-monophosphate dehydrogenase (IMPDH) as an anticancer target: Renewed interest and recent progress


9th Indo Global Summit on Cancer Therapy

November 02-04, 2015 Hyderabad, India

Prashant S Kharkar

NMIMS Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, India

Posters-Accepted Abstracts: J Cancer Sci Ther

Abstract :

IMPDH is an enzyme required for the de novo synthesis of guanine nucleotides. IMPDH inhibitors have found their usefulness as anticancer, antiviral, immunosuppressive, antimicrobial agents, etc. Despite being an old target, there is renewed interest in IMPDH inhibitors as anticancer agents. Several classes of inhibitors have been reported as anticancer agents. The talk will summarize the molecular details of IMPDH as a target and the recent progress made in the design and development of IMPDH inhibitors as anticancer agents, with particular emphasis on the computer-aided molecular design of the inhibitors.

Biography :

Email: Prashant.Kharkar@nmims.edu

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward